Publications by authors named "Mohammed Er-Rajy"

Claim this Profile
C
Computational Analysis of Triazolone-Based Dyes in DSSCs: Exploring Acceptor Terminal for Enhanced Photovoltaic Performance.
Hanane Etabti, Mohammed Er-Rajy, Asmae Fitri, Arunkumar Ammasi, Mohd Shkir

J Fluoresc· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
design of novel dihydropteridone derivatives with oxadiazoles as potent inhibitors of MCF-7 breast cancer cells.
Mourad Aloui, Mohamed El Fadili, Mohammed Er-Rajy, Somdutt Mujwar, Hatem A Abuelizz

Front Chem· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In silico design of novel pyridazine derivatives as balanced multifunctional agents against Alzheimer's disease.
Mourad Aloui, Mohamed El Fadili, Somdutt Mujwar, Mohammed Er-Rajy, Hatem A Abuelizz

Sci Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and evaluation of novel triazole derivatives as potential anti-gout inhibitors: a comprehensive molecular modeling study.
Mohammed Er-Rajy, Mohamed El Fadili, Sara Zarougui, Somdutt Mujwar, Mourad Aloui

Front Chem· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of carbohydrate digestive enzymes by a complementary essential oil blend: in silico and mixture design approaches.
El Hassania Loukili, Mouhcine Fadil, Amal Elrherabi, Mohammed Er-Rajy, Mohamed Taibi

Front Pharmacol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An in-depth study of indolone derivatives as potential lung cancer treatment.
Mohammed Er-Rajy, Mohamed El Fadili, Radwan Alnajjar, Sara Zarougui, Somdutt Mujwar

Sci Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Green Synthesis of Zinc Oxide Nanoparticles for Tetracycline Adsorption: Experimental Insights and DFT Study.
Solhe F Alshahateet, Salah A Al-Trawneh, Mohammed Er-Rajy, Mohammed Zerrouk, Khalil Azzaoui

Plants (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of novel potent selective survivin inhibitors using 2D-QSAR modeling, molecular docking, molecular dynamics, and ADMET properties of new MX-106 hydroxyquinoline scaffold derivatives.
Mourad Aloui, Mohamed El Fadili, Somdutt Mujwar, Sara Er-Rahmani, Hatem A Abuelizz, Mohammed Er-Rajy

Heliyon· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New multifunctional hybrids as modulators of apoptosis markers and topoisomerase II in breast cancer therapy: synthesis, characterization, and and studies.
Heba W Alhamdi, Mohammad Y Alfaifi, Ali A Shati, Serag Eldin I Elbehairi, Mohammed Er-Rajy

RSC Adv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: New multifunctional hybrids as modulators of apoptosis markers and topoisomerase II in breast cancer therapy: synthesis, characterization, and and studies.
Heba W Alhamdi, Mohammad Y Alfaifi, Ali A Shati, Serag Eldin I Elbehairi, Mohammed Er-Rajy

RSC Adv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An in-silico investigation based on molecular simulations of novel and potential brain-penetrant GluN2B NMDA receptor antagonists as anti-stroke therapeutic agents.
Mohamed El Fadili, Mohammed Er-Rajy, Wafa Ali Eltayb, Mohammed Kara, Hamada Imtara

J Biomol Struct Dyn· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In silico insights into the design of novel NR2B-selective NMDA receptor antagonists: QSAR modeling, ADME-toxicity predictions, molecular docking, and molecular dynamics investigations.
Mohamed El Fadili, Mohammed Er-Rajy, Somdutt Mujwar, Abduljelil Ajala, Rachid Bouzammit

BMC Chem· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3D computer modeling of inhibitors targeting the MCF-7 breast cancer cell line.
Sara Zarougui, Mohammed Er-Rajy, Abdelmoujoud Faris, Hamada Imtara, Mohamed El Fadili

Front Chem· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of potential anti-cancer agents as COX-2 inhibitors, using 3D-QSAR modeling, molecular docking, oral bioavailability proprieties, and molecular dynamics simulation.
Mohammed Er-Rajy, Mohamed El Fadili, Abdelmoujoud Faris, Sara Zarougui, Menana Elhallaoui

Anticancer Drugs· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
QSAR modelling, molecular docking, molecular dynamic and ADMET prediction of pyrrolopyrimidine derivatives as novel Bruton's tyrosine kinase (BTK) inhibitors.
Mourad Aloui, Mohammed Er-Rajy, Hamada Imtara, Amina Goudzal, Sara Zarougui

Saudi Pharm J· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of novel anti-cancer drugs targeting TRKs inhibitors based 3D QSAR, molecular docking and molecular dynamics simulation.
Mohammed Er-Rajy, Mohamed El Fadili, Somdutt Mujwar, Sara Zarougui, Menana Elhallaoui

J Biomol Struct Dyn· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
QSAR, ADME-Tox, molecular docking and molecular dynamics simulations of novel selective glycine transporter type 1 inhibitors with memory enhancing properties.
Mohamed El Fadili, Mohammed Er-Rajy, Hamada Imtara, Omar M Noman, Ramzi A Mothana

Heliyon· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3D-QSAR Studies, Molecular Docking, Molecular Dynamic Simulation, and ADMET Proprieties of Novel Pteridinone Derivatives as PLK1 Inhibitors for the Treatment of Prostate Cancer.
Mohammed Er-Rajy, Mohamed El Fadili, Hamada Imtara, Aamir Saeed, Abid Ur Rehman

Life (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
QSAR, ADMET In Silico Pharmacokinetics, Molecular Docking and Molecular Dynamics Studies of Novel Bicyclo (Aryl Methyl) Benzamides as Potent GlyT1 Inhibitors for the Treatment of Schizophrenia.
Mohamed El Fadili, Mohammed Er-Rajy, Mohammed Kara, Amine Assouguem, Assia Belhassan

Pharmaceuticals (Basel)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis